Skip to main content

Advertisement

Log in

Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update

  • Esophagus (JO Clarke, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

The mechanisms underlying eosinophilic esophagitis (EoE) have been intensely investigated, and significant advances have been made in understanding the pathogenesis of EoE. EoE is defined as a chronic immune/antigen-mediated disease, characterized clinically by symptoms of esophageal dysfunction and histologically by an esophageal eosinophilic infiltrate. In this paper, we will review the current knowledge of EoE pathophysiology based on both animal and human data and discuss possible etiologic mechanisms from the genetic and environmental perspectives. EoE is a Th2-predominant inflammatory process triggered by allergens. Proinflammatory cytokines and chemokines recruit eosinophils and other effector cells, such as mast cells, into the esophageal epithelium, where they cause direct damage and promote esophageal remodeling. The genetic expression profile of EoE has been described, and several single nucleotide polymorphisms have been identified and associated with EoE. While this genetic contribution is important, it is difficult to postulate that EoE is primarily a genetic disease. Given the rapid epidemiologic changes in the incidence and prevalence of EoE over the past two decades, environmental factors may be the driving force. While it is not known what causes EoE in an individual patient at a specific time, the current hypothesis is that there is a complex interaction between genetic factors and environmental exposures that remains to be elucidated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Liacouras CA. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20. e6.

    Article  PubMed  Google Scholar 

  2. Furuta GT et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment: sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Gastroenterology. 2007;133(4):1342–63.

    Article  CAS  PubMed  Google Scholar 

  3. Dellon ES. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92. The most recent updated clinical guidelines for diagnosis and management of esophageal eosinophilia and EoE.

    Article  PubMed  Google Scholar 

  4. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Collins MH et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol. 2008;6(6):621–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol. 2011;18(5):335–48.

    Article  CAS  PubMed  Google Scholar 

  7. Aceves SS. Eosinophilic esophagitis. Immunol Allergy Clin N Am. 2015;35:145–59.

    Article  Google Scholar 

  8. Spergel JM et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30–6.

    Article  PubMed  Google Scholar 

  9. Kapel RC et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134(5):1316–21.

    Article  PubMed  Google Scholar 

  10. Dellon ES et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102(10):2300–13.

    Article  PubMed  Google Scholar 

  11. Dellon ES et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305–13.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Prasad GA et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County. Minnesota Clin Gastroenterol Hepatol. 2009;7(10):1055–61.

    Article  PubMed  Google Scholar 

  13. Dellon ES et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12(4):589–96. e1.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mackenzie S et al. Eosinophilic oesophagitis in patients presenting with dysphagia—a prospective analysis. Aliment Pharmacol Ther. 2008;28(9):1140–6.

    Article  CAS  PubMed  Google Scholar 

  15. Veerappan GR et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009;7(4):420–6. e2.

    Article  PubMed  Google Scholar 

  16. Franciosi JP et al. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2009;7(4):415–9.

    Article  PubMed  Google Scholar 

  17. Sperry SL et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2011;107(2):215–21.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):201–18.

    Article  Google Scholar 

  19. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child. 2006;91(12):1000–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hruz P et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128(6):1349–50. e5.

    Article  PubMed  Google Scholar 

  21. Syed A et al. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population‐based study. Aliment Pharmacol Ther. 2012;36(10):950–8.

    Article  CAS  PubMed  Google Scholar 

  22. Prasad GA et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102(12):2627–32.

    Article  PubMed  Google Scholar 

  23. Ricker J. et al. Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Therapeutic Adv Gastroenterol, 2010: p. 1756283X10384172.

  24. Dellon E.S., et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013.

  25. Desai TK et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.

    Article  PubMed  Google Scholar 

  26. Hurtado CW, Furuta GT, Kramer RE. Etiology of esophageal food impactions in children. J Pediatr Gastroenterol Nutr. 2011;52(1):43–6.

    Article  PubMed  Google Scholar 

  27. Kerlin P et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol. 2007;41(4):356–61.

    Article  PubMed  Google Scholar 

  28. Sperry SL et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc. 2011;74(5):985–91.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kidambi T et al. Temporal trends in the relative prevalence of dysphagia etiologies from 1999–2009. World J Gastroenterol: WJG. 2012;18(32):4335.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Dellon ES et al. S1972 increasing incidence of eosinophilic esophagitis: a persistent trend after accounting for procedure indication and biopsy rate. Gastroenterology. 2008;134(4):A-289.

    Google Scholar 

  31. Dellon E, Erichsen R, Baron J. The increasing incidence and prevalence of eosinophilic esophagitis outpaces changes in endoscopic and biopsy practice: National population-based estimates from Denmark (abstr Mo1829). Gastroenterology. 2014;146 suppl 1:665.

    Google Scholar 

  32. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology. 2009;137(4):1238–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Straumann A et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108(6):954–61.

    Article  CAS  PubMed  Google Scholar 

  34. Mishra A et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107(1):83–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 2003;125(5):1419–27.

    Article  CAS  PubMed  Google Scholar 

  36. Akei HS et al. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129(3):985–94.

    Article  CAS  PubMed  Google Scholar 

  37. Dellon ES. The pathogenesis of eosinophilic esophagitis: beyond the eosinophil. Dig Dis Sci. 2013;58(6):1445.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mishra A et al. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol. 2007;81(4):916–24.

    Article  CAS  PubMed  Google Scholar 

  39. Mishra A et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168(5):2464–9.

    Article  CAS  PubMed  Google Scholar 

  40. Masterson JC et al. Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis. Gut. 2014;63(1):43–53. This paper describes development and features of a novel murine model of EoE.

    Article  CAS  PubMed  Google Scholar 

  41. Rayapudi M et al. Invariant natural killer T cell neutralization is a possible novel therapy for human eosinophilic esophagitis. Clin Translat Immunol. 2014;3(1):e9.

    Article  CAS  Google Scholar 

  42. Noti M et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med. 2013;19(8):1005–13. An important invesigation of potential mechanisms of TSLP involvement in EoE pathogenesis, and one of the first reports about the possible role of basophil responses in EoE.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Straumann A, Simon H-U. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115(2):418–9.

    Article  PubMed  Google Scholar 

  44. Jyonouchi S, Brown-Whitehorn TA, Spergel JM. Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin N Am. 2009;29(1):85–97.

    Article  Google Scholar 

  45. Assa’ad AH et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731–8.

    Article  PubMed  Google Scholar 

  46. Simon D et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115(5):1090–2.

    Article  PubMed  Google Scholar 

  47. Assa’ad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am. 2008;18(1):119–32.

    Article  PubMed  Google Scholar 

  48. Penfield JD et al. The role of allergy evaluation in adults with eosinophilic esophagitis. J Clin Gastroenterol. 2010;44(1):22–7.

    Article  PubMed  Google Scholar 

  49. Roy–Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531–5.

    Article  PubMed  Google Scholar 

  50. Rhijn B et al. Birch pollen sensitization with cross‐reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy. 2013;68(11):1475–81.

    Article  PubMed  CAS  Google Scholar 

  51. Spergel JM et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann AllerG, Asthma Immunol. 2005;95(4):336–43.

    Article  Google Scholar 

  52. Spergel JM. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr Opin Allergy Clin Immunol. 2007;7(3):274–8.

    Article  PubMed  Google Scholar 

  53. Kelly KJ et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–12.

    Article  CAS  PubMed  Google Scholar 

  54. Markowitz JE et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.

    Article  CAS  PubMed  Google Scholar 

  55. Kagalwalla AF et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.

    Article  PubMed  Google Scholar 

  56. Liacouras CA et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.

    Article  PubMed  Google Scholar 

  57. Peterson KA et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):759–66.

    Article  CAS  PubMed  Google Scholar 

  58. Assa’ad A. Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allerg, Asthma Immunol. 2005;95(4):309–11.

    Article  Google Scholar 

  59. Henderson CJ et al. Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2012;129(6):1570–8.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Wolf W.A., et al. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clini Gastroenterol Hepatol 2014.

  61. Arias Á et al. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–48. A comprehensive meta-analysis of dietary elimination therapy in EoE, highlighting that the repsonse to removal of food triggers supports the allergic hypothesis of EoE etiology.

    Article  PubMed  Google Scholar 

  62. Gonsalves N et al. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9. e1.

    Article  PubMed  Google Scholar 

  63. Lucendo AJ et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.

    Article  PubMed  Google Scholar 

  64. Molina-Infante J et al. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.

    Article  PubMed  Google Scholar 

  65. Wolf WA, Jerath MR, Dellon ES. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis: JGLD. 2013;22(2):205.

    PubMed  PubMed Central  Google Scholar 

  66. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112(4):796–7.

    Article  PubMed  Google Scholar 

  67. Moawad F et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.

    Article  CAS  PubMed  Google Scholar 

  68. Almansa C et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104(4):828–33.

    Article  PubMed  Google Scholar 

  69. Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41(5):451–3.

    Article  PubMed  Google Scholar 

  70. Simon D et al. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy. 2013;68(7):945–8.

    Article  CAS  PubMed  Google Scholar 

  71. Uzzaman A. and S.H. Cho. Classification of hypersensitivity reactions. In allergy and asthma proceedings. 2012. OceanSide Publications, Inc.

  72. Bryce PJ et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity. 2004;20(4):381–92.

    Article  CAS  PubMed  Google Scholar 

  73. Rocha R et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011;170(11):1471–4.

    Article  CAS  PubMed  Google Scholar 

  74. Clayton F., et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology, 2014. 146(7). This study not only presents the results of a randomized trial of an anti-IgE antibody, but investigates why this medication did not work and identified for the first time the potential role of IgG4 in the pathogenesis of EoE.

  75. Chetty R, Gatter K. CD3: structure, function, and role of immunostaining in clinical practice. J Pathol. 1994;173(4):303–7.

    Article  CAS  PubMed  Google Scholar 

  76. Grunow R et al. Masking of pan-T-cell markers in patients with autoimmune diseases. Dermatologische Monatschrift. 1986;173(7):390–9.

    Google Scholar 

  77. Syrbe U., J. Siveke and A. Hamann. Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? in Springer seminars in immunopathology. 1999. Springer.

  78. Zhang Z, Sferra TJ, Eroglu Y. T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci. 2013;58(6):1497–506.

    Article  CAS  PubMed  Google Scholar 

  79. Straumann A et al. Cytokine expression in healthy and inflamed mucosa: probing the role of eosinophils in the digestive tract. Inflamm Bowel Dis. 2005;11(8):720–6.

    Article  PubMed  Google Scholar 

  80. Blanchard C et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120(6):1292–300.

    Article  CAS  PubMed  Google Scholar 

  81. Blanchard C et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127(1):208–17. e7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Lucendo AJ et al. Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus. Am J Surg Pathol. 2007;31(4):598–606.

    Article  PubMed  Google Scholar 

  83. Blanchard C et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033–41.

    Article  CAS  PubMed  Google Scholar 

  84. Sherrill J et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Blanchard C et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol. 2008;1(4):289–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Cheng E., et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut, 2012: p. gutjnl-2012-302250. This article presents a novel anti-inflammatory/anti-eosinophilic and acid-independent effect of omperazole, a proton pump inhibitor.

  87. Straumann A., et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut, 2009: p. gut. 2009.178558.

  88. Spergel JM et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456–63. e3.

    Article  CAS  PubMed  Google Scholar 

  89. Stein ML et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118(6):1312–9.

    Article  CAS  PubMed  Google Scholar 

  90. Assa’ad AH et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593–604.

    Article  PubMed  CAS  Google Scholar 

  91. Otani IM et al. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2013;131(6):1576–82. e2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Rothenberg, M.E., et al., Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allerg Clin Immunol, 2014. A proof-of-principle study of a new medication class for treatment of EoE.

  93. Johnsson M et al. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J innate Immun. 2011;3(6):594–604.

    Article  CAS  PubMed  Google Scholar 

  94. Lingblom C., et al., Topical corticosteroids do not revert the activated phenotype of eosinophils in eosinophilic esophagitis but decrease surface levels of CD18 resulting in diminished adherence to ICAM-1, ICAM-2, and endothelial cells. Inflammation, 2014: p. 1–13.

  95. Bullock JZ et al. Interplay of adaptive th2 immunity with eotaxin-3/cC chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45(1):22–31.

    Article  CAS  PubMed  Google Scholar 

  96. Rothenberg ME, Hogan SP. The eosinophil. Immunology. 2006;24(1):147.

    Article  CAS  Google Scholar 

  97. Furuta, G.T., et al., The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut, 2012. A novel and minimally invasive technique that could have application for diagnosis and monitoring of EoE in the future.

  98. Moqbel R et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 1995;155(10):4939–47.

    CAS  PubMed  Google Scholar 

  99. Möller G et al. Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol. 1996;14(5):439–43.

    Article  PubMed  Google Scholar 

  100. Blanchard C, Rothenberg ME. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18(1):133–43.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Saffari H et al. Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. J Allergy Clin Immunol. 2014;133(6):1728–34. e1.

    Article  CAS  PubMed  Google Scholar 

  102. Jacoby D, Gleich G, Fryer A. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Investig. 1993;91(4):1314.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Aceves SS et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126(6):1198–204. e4.

    Article  CAS  PubMed  Google Scholar 

  104. Young JD-E et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature. 1986;321(6070):613–6.

    Article  CAS  PubMed  Google Scholar 

  105. O’Donnell MC et al. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Experiment Med. 1983;157(6):1981–91.

    Article  Google Scholar 

  106. Aceves SS et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119(1):206–12.

    Article  CAS  PubMed  Google Scholar 

  107. Kagalwalla AF et al. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol. 2012;129(5):1387–96. e67.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Lucendo AJ et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol. 2011;128(5):1037–46.

    Article  CAS  PubMed  Google Scholar 

  109. Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;303(11):G1175–87.

    Article  CAS  Google Scholar 

  110. Gupta SK et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  111. Kirsch R et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44(1):20–6.

    Article  PubMed  Google Scholar 

  112. Mueller S et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro‐oesophageal reflux disease on oesophageal biopsy material. Histopathology. 2008;53(6):676–84.

    Article  CAS  PubMed  Google Scholar 

  113. Dellon ES et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2010;106(2):264–71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  114. Abonia JP et al. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126(1):140–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Dellon ES et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol. 2006;118(5):1054–9.

    Article  PubMed  Google Scholar 

  117. Adamko D, Lacy P, Moqbel R. Mechanisms of eosinophil recruitment and activation. Curr Allerg Asthma Rep. 2002;2(2):107–16.

    Article  Google Scholar 

  118. Denburg JA et al. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol. 2000;106(5):S242–6.

    Article  CAS  PubMed  Google Scholar 

  119. Sehmi R et al. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol. 1996;15(5):645–55.

    Article  CAS  PubMed  Google Scholar 

  120. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol. 2005;26:877–900.

    Article  CAS  Google Scholar 

  121. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol. 2013;13(2):101–17.

    Article  CAS  PubMed  Google Scholar 

  122. Lexmond WS et al. Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy. Am J Gastroenterol. 2014;109(5):646–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Rajavelu P et al. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am J Physiol-Gastrointestin Liver Physiol. 2012;302(7):G645–54.

    Article  CAS  Google Scholar 

  124. Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol. 2010;24(6):873–82.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Mishra A et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134(1):204–14.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Rubinstein E et al. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2011;53(4):409.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Zuo L et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13Rα2-inhibited pathway. J Immunol. 2010;185(1):660–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Branton MH, Kopp JB. TGF-β and fibrosis. Microbes Infect. 1999;1(15):1349–65.

    Article  CAS  PubMed  Google Scholar 

  129. Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43(2):297–316.

    Article  Google Scholar 

  130. Fontillón M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol. 2012;107(11):1762.

    Article  PubMed  Google Scholar 

  131. Kwiatek MA et al. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Kwiatek MA et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82–90.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Nicodème F et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101–1107 e1. This study shows that esophageal compliance can be used to predict treatment outcomes in EoE, and emphasizes the important role that esophageal remodeling plays in the clinical picture of EoE.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Malerba G et al. Linkage analysis of chromosome 12 markers in Italian families with atopic asthmatic children. Am J Respir Crit Care Med. 2000;162(4):1587–90.

    Article  CAS  PubMed  Google Scholar 

  135. Straumann A et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125(6):1660–9.

    Article  PubMed  Google Scholar 

  136. Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc. 2005;61(1):165–7.

    Article  PubMed  Google Scholar 

  137. Zink DA et al. Familial dysphagia and eosinophilia. Gastrointest Endosc. 2007;65(2):330–4.

    Article  PubMed  Google Scholar 

  138. Alexander ES et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134(5):1084–1092 e1. A comprehensive assessment of the roles of heritability and environment in EoE.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Blanchard C. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(0xc7e4e04):536–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Blanchard C et al. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is upregulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6. Int J Biochem Cell Biol. 2005;37(12):2559–73.

    Article  CAS  PubMed  Google Scholar 

  141. Bhattacharya B et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol. 2007;38(12):1744–53.

    Article  CAS  PubMed  Google Scholar 

  142. Lucendo AJ et al. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol. 2008;103(9):2184–93.

    Article  CAS  PubMed  Google Scholar 

  143. Sherrill J et al. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun. 2014;15(6):361–9. This study expands the known EoE transcriptome, identifying numberous new targets for future pathogenic investigations.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Rothenberg ME et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42(4):289–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Liu YJ. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol. 2009;101:1–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Kottyan LC et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46(8):895–900. One of three GWAS studies of EoE to date, which identified a novel gene locus, CAPN14, as a potential explanation for esophageal specificity in EoE.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Sleiman P.M., et al. GWAS identifies four novel eosinophilic esophagitis loci. Nature communications, 2014. 5.

  148. Larsson H, Bergquist H, Bove M. The incidence of esophageal bolus impaction is there a seasonal variation? Otolaryngol Head Neck Surg. 2011;144(2):186–90.

    Article  PubMed  Google Scholar 

  149. Hurrell JM, Genta RM, Dellon ES. Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol. 2012;107(5):698–706.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Jensen, E., et al. Esophageal eosinophilia and eosinophilic esophagitis are increased in rural areas with low population density: results from a national pathology database. in American Journal Of gastroenterology. 2013. Nature publishing group 75 varick st, 9th flr, New York, NY 10013–1917 USA.

  151. Elitsur Y et al. Seasonal distribution and eosinophilic esophagitis: the experience in children living in rural communities. J Clin Gastroenterol. 2013;47(3):287–8.

    Article  PubMed  Google Scholar 

  152. Spergel JM et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300–6.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Bonis PA. Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis. Immunol Allergy Clin N Am. 2009;29(1):41–52.

    Article  Google Scholar 

  154. Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology. 2010;139(6):1819.

    Article  PubMed  PubMed Central  Google Scholar 

  155. Dellon ES et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 2011;141(5):1586–92.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Ronkainen J et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007;56(5):615–20.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Furuta K et al. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr. 2013;53(1):60.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Elitsur,Y., et al. Does helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter, 2014.

  159. Yamazaki K et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51(11):1934–41.

    Article  CAS  PubMed  Google Scholar 

  160. Jensen ET et al. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(1):67–71. The first study showing that selected early life exposures, such as antibiotic use during infancy, can increase the risk of pediatric development of EoE.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Thomas M. Runge declares no conflict of interest.

Evan S. Dellon reports research funding from Meritage Pharma, Receptos, and Regeneron; consultancy for Aptalis, Novartis, Receptos, Regeneron, and Roche; and an educational grant from Diagnovus, none of which pertain to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Financial Support

This research was supported, in part, by NIH awards T32DK007634 (TR), K23DK090073 (ESD), and R01DK101856 (ESD).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evan S. Dellon.

Additional information

This article is part of the Topical Collection on Esophagus

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Runge, T.M., Dellon, E.S. Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update. Curr Gastroenterol Rep 17, 33 (2015). https://doi.org/10.1007/s11894-015-0458-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11894-015-0458-9

Keywords

Navigation